Calithera
Biosciences Inc. (Nasdaq: CALA) reported a loss for the first quarter but
the company continued to expand and advance its development pipeline. The stock price leaped $4.35 to close at $13.87.
Calithera Biosciences expands development pipeline
May 08, 2015 at 20:14 PM EDT
